CME Group Inc. (NASDAQ:CME)’s share price hit a new 52-week high during trading on Monday . The stock traded as high as $142.33 and last traded at $139.49, with a volume of 924300 shares trading hands. The stock had previously closed at $140.09.
CME has been the subject of several recent analyst reports. BidaskClub raised shares of CME Group from a “buy” rating to a “strong-buy” rating in a research note on Wednesday, September 27th. Barclays PLC lifted their target price on shares of CME Group from $139.00 to $149.00 and gave the company an “overweight” rating in a research report on Tuesday, October 10th. UBS AG reiterated a “buy” rating and set a $135.00 target price (up from $134.00) on shares of CME Group in a research report on Wednesday, September 6th. Royal Bank Of Canada lifted their target price on shares of CME Group from $135.00 to $147.00 and gave the company an “outperform” rating in a research report on Monday, October 16th. Finally, Keefe, Bruyette & Woods reiterated a “hold” rating and set a $127.00 target price on shares of CME Group in a research report on Friday, August 18th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and seven have issued a buy rating to the stock. The company has an average rating of “Buy” and a consensus price target of $141.75.
The firm has a market capitalization of $47,650.00, a price-to-earnings ratio of 29.18, a price-to-earnings-growth ratio of 2.86 and a beta of 0.71. The company has a debt-to-equity ratio of 0.11, a current ratio of 1.05 and a quick ratio of 1.05.
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 27th. Stockholders of record on Friday, December 8th will be issued a $0.66 dividend. The ex-dividend date is Thursday, December 7th. This represents a $2.64 dividend on an annualized basis and a dividend yield of 1.89%. CME Group’s payout ratio is 59.86%.
In related news, CFO John W. Pietrowicz sold 5,175 shares of the company’s stock in a transaction on Thursday, November 2nd. The shares were sold at an average price of $139.70, for a total transaction of $722,947.50. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Hilda Harris Piell sold 714 shares of the company’s stock in a transaction on Wednesday, September 6th. The shares were sold at an average price of $129.00, for a total transaction of $92,106.00. Following the sale, the insider now owns 28,844 shares of the company’s stock, valued at $3,720,876. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 13,939 shares of company stock valued at $1,910,968. Company insiders own 0.57% of the company’s stock.
Large investors have recently bought and sold shares of the stock. Smith Shellnut Wilson LLC ADV purchased a new position in CME Group during the 3rd quarter valued at $231,000. Cypress Capital Group increased its position in CME Group by 1.0% during the 3rd quarter. Cypress Capital Group now owns 64,107 shares of the financial services provider’s stock valued at $8,698,000 after purchasing an additional 645 shares during the period. Belpointe Asset Management LLC purchased a new position in CME Group during the 3rd quarter valued at $380,000. IFM Investors Pty Ltd purchased a new position in CME Group during the 3rd quarter valued at $1,289,000. Finally, Fieldpoint Private Securities LLC purchased a new position in CME Group during the 3rd quarter valued at $250,000. Institutional investors own 82.58% of the company’s stock.
CME Group Company Profile
CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.
Receive News & Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.